Naoya Yuuki

HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions

M. Fukuda, I. Ida, M. Mikuni, 2007, Psychiatry Research: Neuroimaging.

Relationship between age at onset and magnetic resonance image-defined hyperintensities in mood disorders.

M. Fukuda, I. Ida, M. Mikuni, 2008, Journal of Psychiatric Research.

Total and regional brain volume reductions due to the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): A voxel-based morphometric study

M. Fukuda, M. Mikuni, M. Suda, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Brain metabolic changes associated with predispotion to onset of major depressive disorder and adjustment disorder in cancer patients--a preliminary PET study.

I. Ida, N. Oriuchi, H. Kumano, 2007, Journal of psychiatric research.

HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures

M. Fukuda, I. Ida, M. Mikuni, 2005, Acta psychiatrica Scandinavica.

Assessment of the Dexamethasone/CRH Test as a State-Dependent Marker for Hypothalamic-Pituitary-Adrenal (HPA) Axis Abnormalities in Major Depressive Episode: A Multicenter Study

S. Kanba, Takeshi Inoue, S. Nanko, 2006, Neuropsychopharmacology.